FTH
Faeth Therapeutics, Inc.
28.10$
+1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Faeth Therapeutics, Inc. (FTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -20 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -10 | -8.6 | -18 | -30 | -39 | -32 | -25 | -20 | |
| 0.0 | 0.1 | 0.2 | 0.7 | 1.3 | 1.4 | 1.3 | 0.1 | |
| 1.2 | – | 1.5 | 5.7 | 5.8 | 4.5 | 3.1 | 1.3 | |
| 1.5 | 3.5 | -0.4 | 0.1 | 1.0 | -4.3 | -0.5 | -1.6 | |
| 0.0 | 0.1 | 1.2 | 2.0 | 0.3 | 0.2 | 0.1 | 0.0 | |
| 0.0 | -0.1 | -1.4 | -143 | 50 | 38 | 22 | 20 | |
| – | – | – | – | 0.0 | -10 | 0.0 | 0.0 | |
| – | – | – | – | -0.6 | -0.8 | -0.8 | -0.6 | |
| 0.8 | 8.2 | 35 | 164 | -0.3 | -11 | -0.8 | -0.6 | |
| -9.6 | -0.4 | 16 | -9.4 | 11 | -4.8 | -3.0 | -1.3 | |
| -10 | -8.6 | -19 | -32 | -39 | -32 | -25 | -20 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.